NGS-BASED RNA-SEQUENCING MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: BYR-173033 |   Healthcare

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

NGS-Based RNA-Sequencing Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL NGS-BASED RNA-SEQUENCING MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL NGS-BASED RNA-SEQUENCING MARKET

7.1 GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Agilent Technologies

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 BGI Group

16.3 Eurofins Scientific

16.4 Genewiz (Part of Brooks Automation)

16.5 Hamilton Company

16.6 Illumina

16.7 Nugen Technologies (Part of F. Hoffmann-La Roche AG Trading AG)

16.8 Oxford Nanopore Technologies

16.9 Perkinelmer

16.10 Qiagen

16.11 F.Hoffmann-La Roche AG

16.12 Takara Bio

16.13 Thermo Fisher Scientific

16.14 Zymo Research

16.15 Psomagen

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Product & Service
Sample Preparation Products
 o By Workflow
     o Library Preparation & Target Enrichment
     o Quality Control
 o By Method
     o Manual Sample Preparation
     o Microfluidic Sample Preparation
     o Robotic Liquid Handling Sample Preparation
RNA Sequencing Platforms & Consumables
RNA Sequencing Services
Data Analysis, Storage, & Management

By Technology
Sequencing by Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing

By Application
Expression Profiling Analysis
Small RNA Sequencing
De Novo Transcriptome Assembly
Variant Calling & Transcriptome Epigenetics
 
By End User
Research & Academia
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Other End Users

Companies

Agilent Technologies
BGI Group
Eurofins Scientific
Genewiz (Part of Brooks Automation)
Hamilton Company
Illumina
Nugen Technologies (Part of F. Hoffmann-La Roche AG Trading AG)
Oxford Nanopore Technologies
Perkinelmer
Qiagen
F.Hoffmann-La Roche AG
Takara Bio
Thermo Fisher Scientific
Zymo Research
Psomagen

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.